1-4 of 4
Alexandra Koryzna
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)

Clinical Trials & Observations
Asher Chanan-Khan, Kena C. Miller, Kenichi Takeshita, Alexandra Koryzna, Kathleen Donohue, Zale P. Bernstein, Alice Mohr, Donald Klippenstein, Paul Wallace, Jerome B. Zeldis, Christine Berger, Myron S. Czuczman
Journal: Blood
Blood (2005) 106 (10): 3348–3352.
https://doi.org/10.1182/blood-2005-02-0669
Published: 2005
Journal Articles

Phase II Trial of Single Agent Bortezomib (VELCADE®) in Patients with Previously Untreated Multiple Myeloma (MM).

Paul G. Richardson, Asher Chanan-Khan, Robert L. Schlossman, Nikhil C. Munshi, Patrick Wen, Hannah Briemberg, David Kuter, Anne-Louise Oaklander, Sagar Lonial, Hani Hassoun, Deborah Doss, Kathleen Colson, Mary McKenney, Karen Hande, Alexandra Koryzna, Barbara Stoklas, Laura Lunde, Svetlana Gorelik, Cliona McAlister, Andrea Freeman, Diane Warren, Denise Collins, Dixie Esseltine, Anthony Amato, Kenneth C. Anderson
Journal: Blood
Blood (2004) 104 (11): 336.
https://doi.org/10.1182/blood.V104.11.336.336
Published: 2004
Journal Articles

VAD-t (Vincristine, Adriamycin, Dexamethasone and Low-Dose Thalidomide) Is an Effective Initial Therapy with High Response Rates for Patients with Treatment Naïve Multiple Myeloma (MM).

Asher Alban Chanan-Khan, MD, Kena C. Miller, NP, Philip McCarthy, MD, Alexandra Koryzna, RN, Peter Kouides, MD, Kathleen Donohue, Alice Mohr, NP, Zale P. Bernstein, MD, Arif Alam, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2004) 104 (11): 3463.
https://doi.org/10.1182/blood.V104.11.3463.3463
Published: 2004
Journal Articles

Thalidomide (T) in Combination with Fludarabine (F) as Initial Therapy for Patients (pts) with Treatment Naïve Chronic Lymphocytic Leukemia (CLL): Results of a Phase I Trial.

Asher Alban Chanan-Khan, MD, Kena Miller, NP, Alexandra Koryzna, RN, Kenichi Takeshita, MD, Philip McCarthy, MD, Alice Mohr, NP, Kathleen Donohue, Zale P. Bernstein, MD, Arif Alam, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2004) 104 (11): 3476.
https://doi.org/10.1182/blood.V104.11.3476.3476
Published: 2004